ProPhase Labs Inc. (PRPH)
NASDAQ: PRPH
· Real-Time Price · USD
0.34
-0.02 (-5.03%)
At close: Jun 09, 2025, 3:59 PM
ProPhase Labs Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -2.48M | 3.15M | 2.47M | 3.63M | 3.5M | 8.37M | 13.22M | 19.3M | 21.82M | 24.2M | 29.09M | 47.53M | 45.16M | 9.47M | 9.14M | 15.27M |
Cost of Revenue | -3.41M | 3.31M | 2.95M | 4.07M | 6.55M | 6.04M | 6.77M | 8.78M | 10.54M | 12.23M | 10.37M | 18.85M | 29.71M | 5.5M | 4.68M | 6.34M |
Gross Profit | 924K | -165K | -476K | -433K | -3.06M | 2.33M | 6.45M | 10.52M | 11.28M | 11.97M | 18.72M | 28.68M | 15.44M | 3.98M | 4.47M | 8.93M |
Operating Income | -14.57M | -7.94M | -7.83M | -8.3M | -11.35M | -6.48M | -4.66M | 875K | -5.09M | 1.95M | 10.59M | 16.15M | 13.68M | -3.65M | -1.45M | 1.22M |
Interest Income | n/a | n/a | n/a | n/a | 39K | 1K | 27K | 11K | 30K | 25K | 25K | 73K | 111K | 230K | 214K | 87K |
Pretax Income | -15.96M | -9.1M | -8.44M | -8.83M | -11.66M | -6.79M | -4.91M | 564K | -5.19M | 1.78M | 10.41M | 15.91M | 9.62M | -3.98M | -1.4M | 1.06M |
Net Income | -34.36M | -6.59M | -6.15M | -6.26M | -8.75M | -5.14M | -3.44M | 550K | -2.44M | 968K | 7.45M | 12.49M | 10.59M | -3.98M | -1.4M | 1.06M |
Selling & General & Admin | 15.43M | 7.65M | 7.21M | 7.59M | 8.02M | 8.24M | 9.94M | 8.3M | 15.89M | 9.91M | 8.11M | 12.5M | 1.66M | 7.42M | 5.82M | 7.59M |
Research & Development | 61K | 122K | 139K | 272K | 274K | 428K | 572K | 144K | 478K | 110K | 28K | 35K | 104K | 208K | 93K | 115K |
Other Expenses | n/a | n/a | n/a | -18K | 142K | -33K | 8K | 1.2M | 39.94M | n/a | 8.11M | -76K | 9.17M | -296K | n/a | 1.25M |
Operating Expenses | 15.49M | 7.77M | 7.35M | 7.87M | 8.3M | 8.8M | 11.11M | 9.64M | 16.37M | 10.02M | 8.13M | 12.53M | 1.77M | 7.62M | 5.92M | 7.71M |
Interest Expense | 1.03M | 1.16M | 643K | 515K | 494K | 275K | 291K | 215K | 129K | 201K | 201K | 233K | 278K | 296K | 323K | 251K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.12M | 1.48M | 830K | 3.81M |
Cost & Expenses | 12.08M | 11.08M | 10.3M | 11.93M | 14.85M | 14.84M | 17.88M | 18.43M | 26.91M | 22.25M | 18.5M | 31.39M | 31.48M | 13.12M | 10.59M | 14.05M |
Income Tax Expense | 14.56M | -2.51M | -2.29M | -2.57M | -2.91M | -1.64M | -1.47M | 14K | -2.75M | 809K | 2.96M | 3.42M | 3.09M | -296K | -55K | 164K |
Shares Outstanding (Basic) | 20.46M | 19.08M | 18.89M | 18.05M | 18.05M | 17.18M | 16.84M | 16.75M | 16.21M | 20.25M | 18.77M | 18.4M | 15.44M | 15.3M | 15.15M | 14.56M |
Shares Outstanding (Diluted) | 20.46M | 19.08M | 18.89M | 18.05M | 18.05M | 17.18M | 16.84M | 18.06M | 16.21M | 20.25M | 19.27M | 18.74M | 15.44M | 15.44M | 15.15M | 18.2M |
EPS (Basic) | -1.8 | -0.35 | -0.33 | -0.35 | -0.48 | -0.3 | -0.2 | 0.04 | -0.15 | 0.05 | 0.40 | 0.68 | 0.69 | -0.26 | -0.09 | 0.07 |
EPS (Diluted) | -1.8 | -0.35 | -0.33 | -0.35 | -0.48 | -0.3 | -0.2 | 0.03 | -0.15 | 0.05 | 0.39 | 0.67 | 0.69 | -0.26 | -0.09 | 0.06 |
EBITDA | -14.32M | -5.43M | -6.07M | -6.52M | -9.23M | -4.61M | -3.14M | 2.16M | -4.04M | 3.34M | 11.96M | 17.48M | 12.54M | -2.68M | -408K | 1.93M |
EBIT | -14.93M | -7.94M | -7.8M | -8.32M | -11.17M | -6.51M | -4.62M | 779K | -5.06M | 1.98M | 10.61M | 16.14M | 9.9M | -3.68M | -1.07M | 1.31M |
Depreciation & Amortization | 613K | 2.51M | 1.73M | 1.8M | 1.94M | 1.9M | 1.48M | 1.38M | 1.01M | 1.36M | 1.35M | 1.33M | 2.64M | 1.01M | 664K | 621K |